Medicines Targeting Inflammatory Factor IL-1 May Help Combat IBD, Study Suggests

Medicines Targeting Inflammatory Factor IL-1 May Help Combat IBD, Study Suggests
Scientists have discovered a potent inflammatory factor called interleukin (IL)-1  that is released during necroptosis, a type of cell death by suicide often present in inflammatory bowel disease (IBD). The discovery suggests that available medicines targeting IL-1 and future medicines developed to target this molecule may succeed as a new kind of therapeutics for inflammatory diseases

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *